Morphle

Morphle is a medical technology company specializing in AI-enabled robotic plug-and-play whole slide scanners designed for pathology labs, cancer hospitals, and research institutes. Their products focus on automating tissue diagnostics, delivering superior image quality and fast scanning with advanced image analysis tools to enhance accuracy and efficiency in cancer diagnosis workflows.

Core products and services

• Robotic whole slide scanners that provide high-quality, rapid scanning of tissue samples for pathology analysis.

• AI-driven image analysis software for detailed examination and tele-reporting of pathology slides.

• Automated tissue sectioning instruments that prepare thin, consistent microscope slides for diagnostics.

• Solutions for digital pathology workflow enhancement, including data management and remote reporting.

Business model and revenue streams

• Business-to-business model serving pathology labs, hospitals, and research centers primarily through direct sales of medical imaging devices and software solutions.

• Revenue generated from the sale of robotic scanners, imaging software licenses, and service contracts for device maintenance and support.

• Expansion into global markets with focus on increasing adoption of digital pathology platforms for cancer diagnostics and research.